Lining Miao

1.5k total citations
38 papers, 998 citations indexed

About

Lining Miao is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lining Miao has authored 38 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 14 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lining Miao's work include Renal Diseases and Glomerulopathies (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). Lining Miao is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). Lining Miao collaborates with scholars based in China and United States. Lining Miao's co-authors include Wenpeng Cui, Lu Cai, Manyu Luo, Guangdong Sun, Yangwei Wang, Qiaoyan Guo, Yi Tan, Ping Luo, Shujun Liu and Lili Kong and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Life Sciences.

In The Last Decade

Lining Miao

38 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lining Miao China 20 467 265 104 101 89 38 998
Jiagen Wen China 19 515 1.1× 211 0.8× 117 1.1× 75 0.7× 145 1.6× 47 1.1k
Chunling Huang China 21 565 1.2× 200 0.8× 118 1.1× 132 1.3× 92 1.0× 56 1.1k
Yi‐Gang Wan China 18 472 1.0× 332 1.3× 73 0.7× 58 0.6× 53 0.6× 65 999
Xiao-Yong Yu China 14 313 0.7× 313 1.2× 92 0.9× 80 0.8× 45 0.5× 21 788
Yunman Wang China 20 421 0.9× 365 1.4× 84 0.8× 72 0.7× 74 0.8× 36 1.1k
Xiangdong Yang China 18 297 0.6× 251 0.9× 92 0.9× 61 0.6× 72 0.8× 57 975
Jau‐Shyang Huang Taiwan 20 416 0.9× 210 0.8× 54 0.5× 160 1.6× 80 0.9× 35 1.1k
Chitose Suzuki Japan 17 534 1.1× 276 1.0× 137 1.3× 114 1.1× 91 1.0× 26 1.1k
Lucas Opazo-Ríos Spain 12 347 0.7× 291 1.1× 72 0.7× 200 2.0× 82 0.9× 20 1.0k
Xue‐qi Liu China 21 657 1.4× 330 1.2× 141 1.4× 70 0.7× 166 1.9× 33 1.2k

Countries citing papers authored by Lining Miao

Since Specialization
Citations

This map shows the geographic impact of Lining Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lining Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lining Miao more than expected).

Fields of papers citing papers by Lining Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lining Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lining Miao. The network helps show where Lining Miao may publish in the future.

Co-authorship network of co-authors of Lining Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Lining Miao. A scholar is included among the top collaborators of Lining Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lining Miao. Lining Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Xuefeng, Ping Li, Hongli Lin, et al.. (2022). Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: A multicentre, open-label and single-arm clinical trial. Phytomedicine. 99. 154011–154011. 9 indexed citations
3.
Zhang, Yixian, et al.. (2020). Sulforaphane suppresses obesity-related glomerulopathy-induced damage by enhancing autophagy via Nrf2. Life Sciences. 258. 118153–118153. 24 indexed citations
4.
Liu, Lihua, Dong Zhang, Hongxiang Li, et al.. (2019). Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels. Clinical Laboratory. 65(07/2019). 4 indexed citations
5.
Liu, Shengmao, Min Zhang, Yanfeng Wu, et al.. (2018). Application of automated peritoneal dialysis in urgent-start peritoneal dialysis patients during the break-in period. International Urology and Nephrology. 50(3). 541–549. 16 indexed citations
6.
Sun, Jing, Yangwei Wang, Wenpeng Cui, et al.. (2017). Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis. Journal of Diabetes Research. 2017. 1–11. 40 indexed citations
7.
Liu, Yingying, Jing Sun, Lining Miao, et al.. (2016). A porcine model of relief of unilateral ureteral obstruction: study on self-repairing capability over multiple time points. Molecular and Cellular Biochemistry. 419(1-2). 115–123. 4 indexed citations
8.
Liu, Shujun, Qiaoyan Guo, Xiao Liu, et al.. (2016). Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. International Urology and Nephrology. 48(10). 1691–1698. 40 indexed citations
9.
10.
Kong, Lili, Hao Wu, Wenhua Zhou, et al.. (2015). Sirtuin 1: A Target for Kidney Diseases. Molecular Medicine. 21(1). 87–97. 69 indexed citations
11.
Wang, Songyan, Bing Li, Chun Guang Li, Wenpeng Cui, & Lining Miao. (2015). Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy. Journal of Diabetes Research. 2015. 1–11. 21 indexed citations
12.
Yang, Fan, Bing Li, Wenpeng Cui, et al.. (2014). A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases. International Urology and Nephrology. 47(2). 327–333. 11 indexed citations
13.
Wang, Ji, Shujun Liu, Hongyu Li, et al.. (2014). A review of rodent models of peritoneal dialysis and its complications. International Urology and Nephrology. 47(1). 209–215. 7 indexed citations
14.
Wang, Yangwei, Yonggang Wang, Manyu Luo, et al.. (2014). Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(1). 34–46. 90 indexed citations
15.
Liu, Nian, et al.. (2013). Effect of Prolonged Tacrolimus Treatment in Idiopathic Membranous Nephropathy with Nephrotic Syndrome. Pharmacology. 91(5-6). 259–266. 20 indexed citations
16.
Miao, Xiao, Yang Bai, Weixia Sun, et al.. (2012). Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutrition & Metabolism. 9(1). 84–84. 75 indexed citations
17.
Miao, Xiao, Bo Wang, Qiang Chen, et al.. (2012). Deletion of Angiotensin II Type 1 Receptor Gene Attenuates Chronic Alcohol-Induced Retinal Ganglion Cell Death With Preservation of VEGF Expression. Current Eye Research. 38(1). 185–193. 3 indexed citations
18.
Yang, Junling, et al.. (2011). Pulmonary fibrosis: a possible diabetic complication. Diabetes/Metabolism Research and Reviews. 27(4). 311–317. 32 indexed citations
19.
Xie, Yuansheng, Shuxin Liu, Pu Chen, et al.. (2011). Efficacy and Safety of Mizoribine Combined With Losartan in the Treatment of IgA Nephropathy: A Multicenter, Randomized, Controlled Study. The American Journal of the Medical Sciences. 341(5). 367–372. 11 indexed citations
20.
Miao, Lining, et al.. (2006). Combined therapy of low‐dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation. Nephrology. 11(5). 449–454. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiagen Wen Breakdown of academic impact, for papers by Chunling Huang Breakdown of academic impact, for papers by Yi‐Gang Wan Breakdown of academic impact, for papers by Xiao-Yong Yu Breakdown of academic impact, for papers by Yunman Wang Breakdown of academic impact, for papers by Xiangdong Yang Breakdown of academic impact, for papers by Jau‐Shyang Huang Breakdown of academic impact, for papers by Chitose Suzuki Breakdown of academic impact, for papers by Lucas Opazo-Ríos Breakdown of academic impact, for papers by Xue‐qi Liu
Rankless by CCL
2026